{"id":62634,"date":"2026-02-11T22:06:07","date_gmt":"2026-02-11T21:06:07","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/alkermes-to-report-fourth-quarter-and-year-end-financial-results-on-feb-25-2026\/"},"modified":"2026-02-11T22:06:07","modified_gmt":"2026-02-11T21:06:07","slug":"alkermes-to-report-fourth-quarter-and-year-end-financial-results-on-feb-25-2026","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/alkermes-to-report-fourth-quarter-and-year-end-financial-results-on-feb-25-2026\/","title":{"rendered":"Alkermes to Report Fourth Quarter and Year-End Financial Results on Feb. 25, 2026"},"content":{"rendered":"
\n

DUBLIN–(BUSINESS WIRE)–Alkermes plc<\/a> (Nasdaq: ALKS) will host a conference call and webcast presentation at 8:00 a.m. ET (1:00 p.m. GMT) on Wednesday, Feb. 25, 2026 to discuss the company\u2019s fourth quarter and year-end 2025 financial results. Management will also discuss financial expectations for 2026 and provide an update on the company.<\/p>\n

<\/a>
<\/a><\/p>\n

\nThe webcast player and accompanying slides may be accessed on the Investors section of Alkermes\u2019 website at www.alkermes.com<\/a>. The conference call may be accessed by dialing +1 877 407 2988 for U.S. callers and +1 201 389 0923 for international callers. A replay of the webcast will be available approximately two hours after the completion of the event and may be accessed by visiting Alkermes\u2019 website.<\/p>\n

\nAbout Alkermes plc
\n
<\/span><\/b>Alkermes plc (Nasdaq: ALKS), a mid-cap growth and value equity, is a global biopharmaceutical company that seeks to develop innovative medicines in the field of neuroscience. The company has a portfolio of proprietary commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of clinical and preclinical candidates in development for neurological disorders, including narcolepsy and idiopathic hypersomnia. Headquartered in Ireland, Alkermes also has a corporate office and research and development center in Massachusetts and a manufacturing facility in Ohio. For more information, please visit Alkermes\u2019 website at www.alkermes.com<\/a>.<\/p>\n

Contacts<\/b> <\/p>\n

\nAlkermes Contact:
\n
Jamie Constantine
\n
Investor Relations
\n
+1 781 873 2402<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

DUBLIN–(BUSINESS WIRE)–Alkermes plc (Nasdaq: ALKS) will host a conference call and webcast presentation at 8:00 a.m. ET (1:00 p.m. GMT) on Wednesday, Feb. 25, 2026 to discuss the company\u2019s fourth quarter and year-end 2025 financial results. Management will also discuss financial expectations for 2026 and provide an update on the company. The webcast player and … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-62634","6":"format-standard","7":"category-industry"},"yoast_head":"\nAlkermes to Report Fourth Quarter and Year-End Financial Results on Feb. 25, 2026 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/alkermes-to-report-fourth-quarter-and-year-end-financial-results-on-feb-25-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Alkermes to Report Fourth Quarter and Year-End Financial Results on Feb. 25, 2026 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN–(BUSINESS WIRE)–Alkermes plc (Nasdaq: ALKS) will host a conference call and webcast presentation at 8:00 a.m. ET (1:00 p.m. GMT) on Wednesday, Feb. 25, 2026 to discuss the company\u2019s fourth quarter and year-end 2025 financial results. Management will also discuss financial expectations for 2026 and provide an update on the company. The webcast player and ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/alkermes-to-report-fourth-quarter-and-year-end-financial-results-on-feb-25-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-11T21:06:07+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20260210073328\/en\/2654160\/22\/Alkermes_plc_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alkermes-to-report-fourth-quarter-and-year-end-financial-results-on-feb-25-2026\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alkermes-to-report-fourth-quarter-and-year-end-financial-results-on-feb-25-2026\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Alkermes to Report Fourth Quarter and Year-End Financial Results on Feb. 25, 2026\",\"datePublished\":\"2026-02-11T21:06:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alkermes-to-report-fourth-quarter-and-year-end-financial-results-on-feb-25-2026\\\/\"},\"wordCount\":231,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alkermes-to-report-fourth-quarter-and-year-end-financial-results-on-feb-25-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260210073328\\\/en\\\/2654160\\\/22\\\/Alkermes_plc_Logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alkermes-to-report-fourth-quarter-and-year-end-financial-results-on-feb-25-2026\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alkermes-to-report-fourth-quarter-and-year-end-financial-results-on-feb-25-2026\\\/\",\"name\":\"Alkermes to Report Fourth Quarter and Year-End Financial Results on Feb. 25, 2026 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alkermes-to-report-fourth-quarter-and-year-end-financial-results-on-feb-25-2026\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alkermes-to-report-fourth-quarter-and-year-end-financial-results-on-feb-25-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260210073328\\\/en\\\/2654160\\\/22\\\/Alkermes_plc_Logo.jpg\",\"datePublished\":\"2026-02-11T21:06:07+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alkermes-to-report-fourth-quarter-and-year-end-financial-results-on-feb-25-2026\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alkermes-to-report-fourth-quarter-and-year-end-financial-results-on-feb-25-2026\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alkermes-to-report-fourth-quarter-and-year-end-financial-results-on-feb-25-2026\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260210073328\\\/en\\\/2654160\\\/22\\\/Alkermes_plc_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260210073328\\\/en\\\/2654160\\\/22\\\/Alkermes_plc_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alkermes-to-report-fourth-quarter-and-year-end-financial-results-on-feb-25-2026\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Alkermes to Report Fourth Quarter and Year-End Financial Results on Feb. 25, 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Alkermes to Report Fourth Quarter and Year-End Financial Results on Feb. 25, 2026 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/alkermes-to-report-fourth-quarter-and-year-end-financial-results-on-feb-25-2026\/","og_locale":"en_US","og_type":"article","og_title":"Alkermes to Report Fourth Quarter and Year-End Financial Results on Feb. 25, 2026 - Pharma Trend","og_description":"DUBLIN–(BUSINESS WIRE)–Alkermes plc (Nasdaq: ALKS) will host a conference call and webcast presentation at 8:00 a.m. ET (1:00 p.m. GMT) on Wednesday, Feb. 25, 2026 to discuss the company\u2019s fourth quarter and year-end 2025 financial results. Management will also discuss financial expectations for 2026 and provide an update on the company. The webcast player and ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/alkermes-to-report-fourth-quarter-and-year-end-financial-results-on-feb-25-2026\/","og_site_name":"Pharma Trend","article_published_time":"2026-02-11T21:06:07+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20260210073328\/en\/2654160\/22\/Alkermes_plc_Logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/alkermes-to-report-fourth-quarter-and-year-end-financial-results-on-feb-25-2026\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/alkermes-to-report-fourth-quarter-and-year-end-financial-results-on-feb-25-2026\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Alkermes to Report Fourth Quarter and Year-End Financial Results on Feb. 25, 2026","datePublished":"2026-02-11T21:06:07+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/alkermes-to-report-fourth-quarter-and-year-end-financial-results-on-feb-25-2026\/"},"wordCount":231,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/alkermes-to-report-fourth-quarter-and-year-end-financial-results-on-feb-25-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20260210073328\/en\/2654160\/22\/Alkermes_plc_Logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/alkermes-to-report-fourth-quarter-and-year-end-financial-results-on-feb-25-2026\/","url":"https:\/\/pharma-trend.com\/en\/alkermes-to-report-fourth-quarter-and-year-end-financial-results-on-feb-25-2026\/","name":"Alkermes to Report Fourth Quarter and Year-End Financial Results on Feb. 25, 2026 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/alkermes-to-report-fourth-quarter-and-year-end-financial-results-on-feb-25-2026\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/alkermes-to-report-fourth-quarter-and-year-end-financial-results-on-feb-25-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20260210073328\/en\/2654160\/22\/Alkermes_plc_Logo.jpg","datePublished":"2026-02-11T21:06:07+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/alkermes-to-report-fourth-quarter-and-year-end-financial-results-on-feb-25-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/alkermes-to-report-fourth-quarter-and-year-end-financial-results-on-feb-25-2026\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/alkermes-to-report-fourth-quarter-and-year-end-financial-results-on-feb-25-2026\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20260210073328\/en\/2654160\/22\/Alkermes_plc_Logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20260210073328\/en\/2654160\/22\/Alkermes_plc_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/alkermes-to-report-fourth-quarter-and-year-end-financial-results-on-feb-25-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Alkermes to Report Fourth Quarter and Year-End Financial Results on Feb. 25, 2026"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62634","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=62634"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62634\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=62634"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=62634"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=62634"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}